177 related articles for article (PubMed ID: 33759343)
21. miR-216a may inhibit pancreatic tumor growth by targeting JAK2.
Hou BH; Jian ZX; Cui P; Li SJ; Tian RQ; Ou JR
FEBS Lett; 2015 Aug; 589(17):2224-32. PubMed ID: 26149212
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway.
Li YJ; Wang Y; Wang YY
J Cell Physiol; 2019 Jun; 234(6):9577-9591. PubMed ID: 30480801
[TBL] [Abstract][Full Text] [Related]
23. USP39, a direct target of microRNA-133a, promotes progression of pancreatic cancer via the AKT pathway.
Cai J; Liu T; Huang P; Yan W; Guo C; Xiong L; Liu A
Biochem Biophys Res Commun; 2017 Apr; 486(1):184-190. PubMed ID: 28286270
[TBL] [Abstract][Full Text] [Related]
24. Effect of miR-184 on Proliferation and Apoptosis of Pancreatic Ductal Adenocarcinoma and Its Mechanism.
Li S; Li H; Ge W; Song K; Yuan C; Yin R
Technol Cancer Res Treat; 2020; 19():1533033820943237. PubMed ID: 32914707
[TBL] [Abstract][Full Text] [Related]
25. YB-1 expression promotes pancreatic cancer metastasis that is inhibited by microRNA-216a.
Lu J; Li X; Wang F; Guo Y; Huang Y; Zhu H; Wang Y; Lu Y; Wang Z
Exp Cell Res; 2017 Oct; 359(2):319-326. PubMed ID: 28782557
[TBL] [Abstract][Full Text] [Related]
26. Deletion of pancreas-specific miR-216a reduces beta-cell mass and inhibits pancreatic cancer progression in mice.
Erener S; Ellis CE; Ramzy A; Glavas MM; O'Dwyer S; Pereira S; Wang T; Pang J; Bruin JE; Riedel MJ; Baker RK; Webber TD; Lesina M; Blüher M; Algül H; Kopp JL; Herzig S; Kieffer TJ
Cell Rep Med; 2021 Nov; 2(11):100434. PubMed ID: 34841287
[TBL] [Abstract][Full Text] [Related]
27. Global targetome analysis reveals critical role of miR-29a in pancreatic stellate cell mediated regulation of PDAC tumor microenvironment.
Dey S; Liu S; Factora TD; Taleb S; Riverahernandez P; Udari L; Zhong X; Wan J; Kota J
BMC Cancer; 2020 Jul; 20(1):651. PubMed ID: 32660466
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression.
Zhou YM; Yao YL; Liu W; Shen XM; Shi LJ; Wu L
Cancer Biomark; 2020; 29(1):51-67. PubMed ID: 32568182
[TBL] [Abstract][Full Text] [Related]
29. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S
J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515
[TBL] [Abstract][Full Text] [Related]
30. MiR-331-3p inhibits proliferation and promotes apoptosis by targeting HER2 through the PI3K/Akt and ERK1/2 pathways in colorectal cancer.
Zhao D; Sui Y; Zheng X
Oncol Rep; 2016 Feb; 35(2):1075-82. PubMed ID: 26718987
[TBL] [Abstract][Full Text] [Related]
31. Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin.
Li CH; To KF; Tong JH; Xiao Z; Xia T; Lai PB; Chow SC; Zhu YX; Chan SL; Marquez VE; Chen Y
Gastroenterology; 2013 May; 144(5):1086-1097.e9. PubMed ID: 23395645
[TBL] [Abstract][Full Text] [Related]
32. miR-212-5p exerts tumor promoter function by regulating the Id3/PI3K/Akt axis in lung adenocarcinoma cells.
Chen FF; Sun N; Wang Y; Xi HY; Yang Y; Yu BZ; Li XJ
J Cell Physiol; 2020 Oct; 235(10):7273-7282. PubMed ID: 32039486
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling.
Chang RM; Xu JF; Fang F; Yang H; Yang LY
Tumour Biol; 2016 Aug; 37(8):10609-19. PubMed ID: 26861561
[TBL] [Abstract][Full Text] [Related]
34. MiR-590 Suppresses Proliferation and Induces Apoptosis in Pancreatic Cancer by Targeting High Mobility Group A2.
Wang YD; Mao JD; Wang JF; Xu MQ
Technol Cancer Res Treat; 2020; 19():1533033820928143. PubMed ID: 32588766
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-628-5p inhibits invasion and migration of human pancreatic ductal adenocarcinoma via suppression of the AKT/NF-kappa B pathway.
Zhou L; Jiao X; Peng X; Yao X; Liu L; Zhang L
J Cell Physiol; 2020 Nov; 235(11):8141-8154. PubMed ID: 31957029
[TBL] [Abstract][Full Text] [Related]
36. Derivation and Validation of the Potential Core Genes in Pancreatic Cancer for Tumor-Stroma Crosstalk.
Xue R; Hua L; Xu W; Gao Y; Pang Y; Hao J
Biomed Res Int; 2018; 2018():4283673. PubMed ID: 30519576
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer.
Yang J
Med Oncol; 2020 Mar; 37(5):34. PubMed ID: 32219571
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA PXN-AS1 suppresses pancreatic cancer progression by acting as a competing endogenous RNA of miR-3064 to upregulate PIP4K2B expression.
Yan J; Jia Y; Chen H; Chen W; Zhou X
J Exp Clin Cancer Res; 2019 Sep; 38(1):390. PubMed ID: 31488171
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer.
Khan S; Ebeling MC; Zaman MS; Sikander M; Yallapu MM; Chauhan N; Yacoubian AM; Behrman SW; Zafar N; Kumar D; Thompson PA; Jaggi M; Chauhan SC
Oncotarget; 2014 Sep; 5(17):7599-609. PubMed ID: 25277192
[TBL] [Abstract][Full Text] [Related]
40. Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Wang L; Zhang B; Zheng W; Kang M; Chen Q; Qin W; Li C; Zhang Y; Shao Y; Wu Y
Sci Rep; 2017 Jul; 7(1):5384. PubMed ID: 28710412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
